The effect of phlebotomy versus birth control pills in women with polycystic ovaries

Effect of phlebotomy versus oral contraceptives containing cyproterone acetateon the clinical and biochemical parameters in women with polycystic ovary syndrome

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190618043934N17

Enrollment

Registered

2023-04-24

Start date

2023-04-20

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovarian syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: First intervention group:patients in phlebotomy group A, 450 cc of whole blood, or 200 to 220 ml of red blood cells,are drawn in the emergency room during the folli

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Having polycystic ovary syndrome Age 18-45 years Hemoglobin higher than 12 Milligrams per deciliter Ferritin higher than 20 nanograms per deciliter

Exclusion criteria

Exclusion criteria: Taking medicine Having high blood pressure Having heart disease Having diabetes

Design outcomes

Primary

Measure	Time frame
Testosterone. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: In patients' serum samples using Monobind's kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mahla Pakdin

Birjand University of Medical Sciences

mahlapakdin@yahoo.com+98 56 3232 3232

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026